← Browse by Condition
Medical Condition

refractory acute leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07356154 Phase 1, Phase 2
Recruiting

A Study of Revumenib and Mezigdomide in People With Leukemia

Enrollment
52 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →